BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6723575)

  • 21. Autoparacrine action of vasoactive intestinal peptide on dopaminergic control of prolactin secretion.
    Balsa JA; Sánchez-Franco F; Lorenzo MJ; Pazos F; Lara JI; Cacicedo L
    Endocrinology; 1996 Feb; 137(2):508-13. PubMed ID: 8593796
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypothalamic and pituitary sites of action of oxytocin to alter prolactin secretion in the rat.
    Lumpkin MD; Samson WK; McCann SM
    Endocrinology; 1983 May; 112(5):1711-7. PubMed ID: 6403333
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The stimulatory and inhibitory effects of dopamine on prolactin secretion involve different G-proteins.
    Burris TP; Nguyen DN; Smith SG; Freeman ME
    Endocrinology; 1992 Feb; 130(2):926-32. PubMed ID: 1733734
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stimulatory effect of estrogen on prolactin secretion from primate pituitary cells cultured on extracellular matrix and in serum-free medium.
    Bethea CL
    Endocrinology; 1984 Aug; 115(2):443-51. PubMed ID: 6745162
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paracrine cell to cell interactions determine the effects of pituitary adenylate cyclase activating polypeptide (PACAP) on in vitro prolactin release from rat pituitary cells.
    Benter S; Leonhardt S; Wuttke W; Jarry H
    Exp Clin Endocrinol Diabetes; 1995; 103(6):386-90. PubMed ID: 8788312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prolactin control of growth and prolactin autoregulation in cultured human pituitary cells.
    Hosojima H; Wyche JH
    Horm Res; 1985; 21(4):240-5. PubMed ID: 4007784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is there a direct correlation between the activities of various lysosomal enzymes and prolactin secretion in the rat anterior pituitary?
    Nagy I; Rappay G; Makara GB; Horvath G; Bacsy E; MacLeod RM
    Endocrinology; 1983 Feb; 112(2):470-5. PubMed ID: 6848358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of hypothyroidism and hypoprolactinemia by growth hormone producing rat pituitary tumors.
    Seo H; Refetoff S; Fang VS
    Endocrinology; 1977 Jan; 100(1):216-26. PubMed ID: 401484
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transient dopaminergic inhibition of prolactin release from hybrid cells derived by fusion of normal rat pituitary and GH4C1 tumor cells.
    Day RN; Hinkle PM
    Endocrinology; 1988 May; 122(5):2165-73. PubMed ID: 3129281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dihydropyridine-sensitive calcium channel activity related to prolactin, growth hormone, and luteinizing hormone release from anterior pituitary cells in culture: interactions with somatostatin, dopamine, and estrogens.
    Drouva SV; Rerat E; Bihoreau C; Laplante E; Rasolonjanahary R; Clauser H; Kordon C
    Endocrinology; 1988 Dec; 123(6):2762-73. PubMed ID: 2461851
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of estradiol on prolactin and growth hormone messenger RNAs in cultured normal and neoplastic (MtT/W15 and GH3) rat pituitary cells.
    Song JY; Jin L; Lloyd RV
    Cancer Res; 1989 Mar; 49(5):1247-53. PubMed ID: 2917354
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chloroquine affects prolactin secretion and Golgi morphology in the mammotroph.
    Conconi MV; Walker AM
    Endocrinology; 1984 Mar; 114(3):725-34. PubMed ID: 6697960
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyperprolactinemia after neonatal prolactin (PRL) deficiency in rats: evidence for altered anterior pituitary regulation of PRL secretion.
    Shah GV; Shyr SW; Grosvenor CE; Crowley WR
    Endocrinology; 1988 May; 122(5):1883-9. PubMed ID: 3129278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification by the sequential cell immunoblot assay of a subpopulation of rat dopamine-unresponsive lactotrophs.
    Arita J; Kojima Y; Kimura F
    Endocrinology; 1991 Apr; 128(4):1887-94. PubMed ID: 2004608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The inhibition of phosphatidylinositol turnover: a possible postreceptor mechanism for the prolactin secretion-inhibiting effect of dopamine.
    Canonico PL; Valdenegro CA; MacLeod RM
    Endocrinology; 1983 Jul; 113(1):7-14. PubMed ID: 6861715
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence for the secretion of decidual luteotropin: a prolactin-like hormone produced by rat decidual cells.
    Herz Z; Khan I; Jayatilak PG; Gibori G
    Endocrinology; 1986 Jun; 118(6):2203-9. PubMed ID: 3698911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Release of prolactin and growth-hormone by pituitary grafts. Role of the neurointermediate lobe.
    Settembrini BP; Gallardo MG; Tramezzani JH
    Acta Physiol Pharmacol Ther Latinoam; 1991; 41(3):337-47. PubMed ID: 1843868
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bombesin stimulates prolactin and growth hormone release by pituitary cells in culture.
    Westendorf JM; Schonbrunn A
    Endocrinology; 1982 Feb; 110(2):352-8. PubMed ID: 6799271
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A cleaved form of prolactin in the mouse pituitary gland: identification and comparison of in vitro synthesis and release in strains with high and low incidences of mammary tumors.
    Sinha YN; Gilligan TA
    Endocrinology; 1984 Jun; 114(6):2046-53. PubMed ID: 6723574
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cortistatin inhibits growth hormone release from human fetal and adenoma pituitary cells and prolactin secretion from cultured prolactinomas.
    Rubinfeld H; Hadani M; Barkai G; Taylor JE; Culler MD; Shimon I
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2257-63. PubMed ID: 16595604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.